AAV-7F9-Fc

N/A

Report date: 2025/01/26 18:11:22

Base Information

Drug NameAAV-7F9-Fc
Drug Alias Nameanti-methamphetamine antibody gene therapy (University of Arkansas for Medical Sciences)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAmphetamine-Related DisordersFeverInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Arkansas For Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Arkansas For Medical Sciences
Inactive CompaniesN/A
Active IndicationsAmphetamine-Related DisordersFeverInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A